Olema Pharmaceuticals, Inc.

OLMANASDAQHealthcare● Active

$9.96

$-0.35(-3.39%)

Market Cap$869980811

P/E Ratio—

52W High$36.259

52W Low$3.89

Avg Volume1.5M

Open$10.40

Beta2.00

Free Cash Flow Financials Revenue

Olema Pharmaceuticals, Inc. (OLMA) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

OLMA · free cash flow · updated Jun 8, 2026

Core FCF metrics

OLMA · FCF · TTM · margin & CAGR

Free cash flow was −$146.7M for FY2025 (fiscal year ending 2025-12-31), down 40.4% year-over-year

FY2025 Free Cash Flow−$146.7M▼ -40.4% YoY

Trailing 12M (TTM)−$148.7Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

OLMA · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$146.7M(0M)−$146.7M▼ 40.4%—

FY2024−$104.4M(0M)−$104.5M▼ 24.8%—

FY2023−$83.7M(0M)−$83.7M▼ 1.6%—

FY2022−$82.1M(0M)−$82.4M▼ 57.7%—

FY2021−$50.7M(2M)−$52.3M▼ 162.3%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

OLMA · P/FCF · FCF yield · FCF per share

Olema Pharmaceuticals, Inc. (OLMA) reported negative free cash flow of −$0.15B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

OLMA · cash flow statement · operating / investing / financing

For FY2025, Olema Pharmaceuticals, Inc. generated −$146.7M in operating cash flow and spent 0M in capital expenditures, yielding −$146.7M in free cash flow.

Operating Activities

−$146.7M

Cash from core business operations

2025-12-31

Investing Activities

−$155.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$211.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$146.7M) − |CapEx| (0M) = FCF (−$146.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

OLMA vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Olema Pharmaceuticals, Inc.YOU

OLMA

−$146.7M-40.4%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Olema Pharmaceuticals, Inc. (OLMA) reported free cash flow of −$146.7M for FY2025 (fiscal year ending 2025-12-31), down 40.4% year-over-year.

Olema Pharmaceuticals, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 8 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

OLMA free cash flow · 8 questions

Olema Pharmaceuticals, Inc. free cash flow was −$146.7M for FY2025, down 40.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$148.7M.

OLMA free cash flowOLMA FCFOLMA FCF 2025OLMA free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Olema Pharmaceuticals, Inc. · Olema Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026